South Korea · Delayed Price · Currency is KRW Pharmsville Statistics
Total Valuation
Pharmsville has a market cap or net worth of KRW 27.63 billion. The enterprise value is -11.76 billion.
| Market Cap | 27.63B |
| Enterprise Value | -11.76B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
Pharmsville has 7.73 million shares outstanding. The number of shares has increased by 0.08% in one year.
| Current Share Class | 7.73M |
| Shares Outstanding | 7.73M |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 62.91% |
| Owned by Institutions (%) | n/a |
| Float | 2.00M |
Valuation Ratios
The trailing PE ratio is 9.24.
| PE Ratio | 9.24 |
| Forward PE | n/a |
| PS Ratio | 2.33 |
| PB Ratio | 0.41 |
| P/TBV Ratio | 0.41 |
| P/FCF Ratio | 18.21 |
| P/OCF Ratio | 18.18 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.93 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -7.75 |
Financial Position
The company has a current ratio of 27.65, with a Debt / Equity ratio of 0.00.
| Current Ratio | 27.65 |
| Quick Ratio | 26.66 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.01 |
| Interest Coverage | -992.63 |
Financial Efficiency
Return on equity (ROE) is 4.54% and return on invested capital (ROIC) is -2.37%.
| Return on Equity (ROE) | 4.54% |
| Return on Assets (ROA) | -0.75% |
| Return on Invested Capital (ROIC) | -2.37% |
| Return on Capital Employed (ROCE) | -1.21% |
| Weighted Average Cost of Capital (WACC) | 4.66% |
| Revenue Per Employee | 424.17M |
| Profits Per Employee | 106.74M |
| Employee Count | 28 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 2.74 |
Taxes
In the past 12 months, Pharmsville has paid 752.90 million in taxes.
| Income Tax | 752.90M |
| Effective Tax Rate | 20.00% |
Stock Price Statistics
The stock price has decreased by -0.42% in the last 52 weeks. The beta is 0.07, so Pharmsville's price volatility has been lower than the market average.
| Beta (5Y) | 0.07 |
| 52-Week Price Change | -0.42% |
| 50-Day Moving Average | 3,589.80 |
| 200-Day Moving Average | 3,702.83 |
| Relative Strength Index (RSI) | 48.26 |
| Average Volume (20 Days) | 18,333 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pharmsville had revenue of KRW 11.88 billion and earned 2.99 billion in profits. Earnings per share was 386.75.
| Revenue | 11.88B |
| Gross Profit | 7.50B |
| Operating Income | -823.88M |
| Pretax Income | 3.76B |
| Net Income | 2.99B |
| EBITDA | -227.89M |
| EBIT | -823.88M |
| Earnings Per Share (EPS) | 386.75 |
Balance Sheet
The company has 39.53 billion in cash and 15.33 million in debt, with a net cash position of 39.51 billion or 5,112.52 per share.
| Cash & Cash Equivalents | 39.53B |
| Total Debt | 15.33M |
| Net Cash | 39.51B |
| Net Cash Per Share | 5,112.52 |
| Equity (Book Value) | 67.76B |
| Book Value Per Share | 8,756.57 |
| Working Capital | 40.17B |
Cash Flow
In the last 12 months, operating cash flow was 1.52 billion and capital expenditures -2.86 million, giving a free cash flow of 1.52 billion.
| Operating Cash Flow | 1.52B |
| Capital Expenditures | -2.86M |
| Depreciation & Amortization | 595.99M |
| Net Borrowing | -6.79M |
| Free Cash Flow | 1.52B |
| FCF Per Share | 196.31 |
Margins
Gross margin is 63.15%, with operating and profit margins of -6.94% and 25.16%.
| Gross Margin | 63.15% |
| Operating Margin | -6.94% |
| Pretax Margin | 31.70% |
| Profit Margin | 25.16% |
| EBITDA Margin | -1.92% |
| EBIT Margin | -6.94% |
| FCF Margin | 12.77% |
Dividends & Yields
This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 5.59%.
| Dividend Per Share | 200.00 |
| Dividend Yield | 5.59% |
| Dividend Growth (YoY) | 100.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 25.86% |
| Buyback Yield | -0.08% |
| Shareholder Yield | 5.52% |
| Earnings Yield | 10.82% |
| FCF Yield | 5.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pharmsville has an Altman Z-Score of 12.61 and a Piotroski F-Score of 4.
| Altman Z-Score | 12.61 |
| Piotroski F-Score | 4 |